Your browser doesn't support javascript.
loading
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer.
Koh, Siang-Boon; Ross, Kenneth; Isakoff, Steven J; Melkonjan, Nsan; He, Lei; Matissek, Karina J; Schultz, Andrew; Mayer, Erica L; Traina, Tiffany A; Carey, Lisa A; Rugo, Hope S; Liu, Minetta C; Stearns, Vered; Langenbucher, Adam; Saladi, Srinivas Vinod; Ramaswamy, Sridhar; Lawrence, Michael S; Ellisen, Leif W.
Afiliação
  • Koh SB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Ross K; Harvard Medical School, Boston, Massachusetts.
  • Isakoff SJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Melkonjan N; Harvard Medical School, Boston, Massachusetts.
  • He L; Broad Institute of MIT and Harvard University, Cambridge, Massachusetts.
  • Matissek KJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Schultz A; Harvard Medical School, Boston, Massachusetts.
  • Mayer EL; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Traina TA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Carey LA; Harvard Medical School, Boston, Massachusetts.
  • Rugo HS; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Liu MC; Harvard Medical School, Boston, Massachusetts.
  • Stearns V; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Langenbucher A; Harvard Medical School, Boston, Massachusetts.
  • Saladi SV; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ramaswamy S; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lawrence MS; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Ellisen LW; University of California San Francisco, San Francisco, California.
Clin Cancer Res ; 27(17): 4883-4897, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34168046
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Ativadoras de GTPase / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Ativadoras de GTPase / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article